Germany – Pharmaceutical products – Open-House-Rabattverträge 2024-07
Opportunity Score
Confidence: 35%
Complexity: medium
746 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Open-house framework agreement for non-exclusive pharmaceutical discount contracts (Rabattverträge) under German SGB V. 27 lots covering different active substances. All qualified pharmaceutical entrepreneurs can join at any time until 30 June 2028. Submission via email with qualified electronic signature or by post. No guaranteed volume or exclusivity.
Strengths
Documents available
Open procedure
Medium complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Must be a pharmaceutical entrepreneur as defined in §4 Abs. 18 AMG.
- Must have seat in Germany, EU, or EEA (per §9 Abs. 2 AMG).
- Local representatives are only eligible if they themselves are pharmaceutical entrepreneurs for the offered medicinal products.
Buyer
Name
Techniker Krankenkasse
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Lots (27)
Discount agreement for Abiraterone 223.16 mg N2, participating health insurers: TK, HEK, hkk.
Discount agreement for Abiraterone 892.64 mg 28 pieces, participating health insurers: TK, HEK, hkk.
Discount agreement for Baclofen parenteral form, participating health insurers: TK, HEK, hkk.
Procurement Details
Publication
14 Jun 2026
Deadline
30 Jun 2028, 21:58
Procedure
open
Contract
supplies
Language
DEU
Publication #
409420-2026
Classification
Performance: Germany
Documents (1)
Opportunity Score
Confidence: 35%
Complexity: medium
746 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation